Oxford BioMedica (OXBDF)
(Delayed Data from OTC)
$4.60 USD
-0.08 (-1.60%)
Updated Aug 23, 2024 11:37 AM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Price, Consensus and EPS Surprise
OXBDF 4.60 -0.08(-1.60%)
Will OXBDF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OXBDF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for OXBDF
Oxford Biomedica Enhances Board, Fuels Innovation
Oxford Biomedica sees 1H revenue GBP 50M
Buy Rating Affirmed for Oxford BioMedica on Strong Performance and Robust Market Positioning
Oxford Biomedica Optimistic Amid 2024 Growth
Oxford Biomedica Announces Voting Rights Total